Cumulative incidence of T1D development in subjects with single IAb in TrialNet Pathway to Prevention Study.
Panel A: Cumulative incidence of T1D development in subjects with single GADA positive by RBA, divided with ECL-GADA positive vs ECL-GADA negative (p= 0.0009).
Panel B: Cumulative incidence of T1D development in subjects with single IAA positive by RBA, divided with ECL-IAA positive vs ECL-IAA negative (p< 0.0001).